Verrica Pharmaceuticals Inc

NASDAQ:VRCA  
6.98
+0.08 (+1.16%)
5:00:54 PM EDT: $7.10 +0.12 (+1.72%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)296.08M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.72 Million
Adjusted EPS-$0.45
See more estimates
10-Day MA$6.85
50-Day MA$5.69
200-Day MA$5.02
See more pivots

Verrica Pharmaceuticals Inc Stock, NASDAQ:VRCA

44 West Gay Street, Suite 400, West Chester, Pennsylvania 19380
United States of America
Phone: +1.434.453.3300
Number of Employees: 100
http://www.verrica.com

Description

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.